Bioorg. Med. Chem. Lett. 2008, 18(16), 4713-4715.

Synthesis of 6- or 4-functionalized indoles via a reductive cyclization approach and evaluation as aromatase inhibitors.

Bioorg. Med. Chem. Lett. 2006, 16, 1134-1137.

Synthesis and biologicol evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: Potent and selective aromatase inhibitors.

J. Enz. Inh. Med. Chem. 2005, 20, 581-585.

Three-Dimensional Model of Cytochrome P450 Human Aromatase.

J. Enz. Inh. Med. Chem. 2004, 19, 549-557.

2- and 3-[(Aryl)(azolyl)methyl]indoles as potential non-steroidal aromatase inhibitors.

Bioorg. Med. Chem. Lett. 2003, 13, 1553-1555.

Preparation and Pharmacological Profile of 7-(a-Azolylbenzyl)-1H-Indoles and Indolines as New Aromatase Inhibitors.

Ann. Pharm. Fr. 2000, 58, 316-320. 

Dérivés indoliques à activités anti-inflammatoire ou antitumorale. 

J. Pharm. Pharmacol. 1999, 51 (S), 113.

New 7-(a-azolylbenzyl)-indoles and indolines acting as P450 aromatase inhibitors. 

Bioorg. Med. Chem. Lett. 1999, 9, 333-336.

New selective nonsteroidal aromatase inhibitors: synthesis and inhibitory activity of 2, 3 or 5-(a-azolylbenzyl)-1H-indoles.